MedPath

Sertraline Hydrochloride

Sertraline HCL 100mg Tablets

Approved
Approval ID

f8c45a99-18ed-0e1f-e053-6394a90a2d52

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 7, 2023

Manufacturers
FDA

Advanced Rx Pharmacy of Tennessee, LLC

DUNS: 117023142

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sertraline Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code80425-0310
Application NumberANDA077206
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sertraline Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateApril 7, 2023
FDA Product Classification

INGREDIENTS (1)

SERTRALINE HYDROCHLORIDEActive
Quantity: 100 mg in 1 1
Code: UTI8907Y6X
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sertraline Hydrochloride - FDA Drug Approval Details